| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |